Positron (POSC, $1.48) was a top loser over the last three months, falling -3 to $1.48 per share. A.I.dvisor analyzed 396 stocks in the Medical Specialties Industry for the 3-month period ending May 20, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.